Top of this page
Skip navigation, go straight to the content
UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology.
We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to become the patient-preferred biopharma leader by delivering medicines and solutions that improve lives. Our commitment to value is a promise to bring together the talent, expertise, tools and scientific know-how required to serve patients in need.
At UCB, we take our responsibility
to the planet very seriously.
UCB Ventures, our strategic corporate venture fund established in 2017
Twitter Feed
-
#DYK about our commitment to improving our carbon footprint, energy efficiency, water conservation & waste control #sustainability #InspiredByPatients #DrivenByScience https://t.co/6WEtqvZyJn https://t.co/haIePd4TLA
— UCB News (@ucb_news) 21.08.2019 -
We believe in #diversity. We have an almost 50:50 balance between men and women across our organization ????????????????????????#CSR #GenderEquality https://t.co/LcOv2rPIhF https://t.co/4NXbrBwYHn
— UCB News (@ucb_news) 20.08.2019 -
Find out how the #MaybeBaby project is supporting young people in the UK and Ireland living with #arthritis and #psoriasis to plan their futures today. https://t.co/r63gorBo0M https://t.co/TYBOmwp69V
— UCB News (@ucb_news) 19.08.2019
